Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $88.48 | $20.79 | 325.56% | 192.35x | 168.98x | 12.02x | 14.89x | 1.62x | $119.79M | 1.30% | $637.99M | 6.11 | $9.40B | -1,368.97 | ||
| LQDA | LIQUIDIA CORP | $79.32 | $17.70 | 348.25% | 330.50x | 23.22x | 24.23x | 64.96x | 1.63x | $41.15M | 0.59% | $108.58M | 1.23 | $7.01B | 130.90 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $301.67 | $93.71 | 221.91% | 69.19x | 40.00x | 9.35x | 37.45x | 1.44x | $641.34M | 1.60% | $1.08B | 8.09 | $41.54B | 44.93 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.00 | $2.93 | 172.97% | 114.29x | 74.70x | 4.33x | 106.15x | 1.05x | $47.52M | 3.49% | $13.01M | 0.08 | $1.53B | 28.60 | ||
| KRYS | KRYSTAL BIOTECH INC | $371.58 | $95.58 | 288.75% | 47.95x | 46.73x | 26.08x | 8.58x | 2.29x | $237.38M | 2.18% | $1.28B | 43.59 | $10.46B | 48.90 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $62.89 | $17.36 | 262.30% | 64.17x | 49.26x | 6.38x | 7.99x | 1.74x | $164.23M | 3.41% | $605.69M | 7.92 | $4.66B | 41.77 | ||
| VCEL | VERICEL CORP | $45.15 | $9.16 | 393.15% | 105.00x | 93.65x | 7.85x | 6.47x | 2.21x | $47.49M | 2.07% | $356.23M | 7.02 | $2.29B | 56.68 | ||
| ADMA | ADMA BIOLOGICS INC | $8.61 | $9.85 | -12.61% | 12.48x | 9.41x | 3.99x | 5.11x | 0.47x | $107.90M | 5.31% | $390.33M | 1.65 | $2.06B | 9.28 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.82 | $41.87 | 38.10% | 41.30x | 15.25x | 3.43x | 1.80x | 0.56x | $767.06M | 6.89% | $6.21B | 32.27 | $9.53B | 19.76 | ||
| HALO | HALOZYME THERAPEUTICS INC | $77.01 | $71.49 | 7.72% | 26.02x | 9.29x | 6.03x | 41.59x | 0.46x | $667.65M | 7.34% | $219.64M | 1.86 | $10.97B | 17.58 | ||
| RPRX | ROYALTY PHARMA PLC | $55.78 | $39.97 | 39.57% | 29.20x | 10.46x | 9.98x | 3.23x | 0.63x | $2.34B | 9.61% | $9.94B | 22.75 | $40.49B | 34.80 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $13.81 | $16.00 | -13.69% | 6.74x | 28.81x | 6.60x | 3.97x | 0.90x | $56.42M | 6.99% | $205.80M | 3.52 | $721.93M | 4.99 | ||
| ASND | ASCENDIS PHARMA A | $267.79 | $80.86 | 231.17% | 28.38x | 17.95x | 16.33x | 28.97x | 2.90x | $52.94M | 0.32% | $574.09M | 9.24 | $17.01B | 182.44 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $237.51 | $49.50 | 379.78% | 505.34x | 9.23x | 3.31x | 3.29x | 1.70x | $1.30B | 8.83% | $4.53B | 73.22 | $18.46B | 27.35 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $312.01 | $94.58 | 229.89% | 39.49x | 34.38x | 22.60x | 6.27x | 1.99x | $122.22M | 1.97% | $997.32M | 50.16 | $6.59B | 29.22 | ||
| TGTX | TG THERAPEUTICS INC | $53.52 | $17.07 | 213.53% | 16.62x | 38.26x | 11.04x | 14.05x | 263.38x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.50B | 56.67 | ||
| TECH | BIO-TECHNE CORP | $71.00 | $16.82 | 322.15% | 100.00x | 33.98x | 9.17x | 5.33x | 1.83x | $269.60M | 2.43% | $2.09B | 13.34 | $11.20B | 43.74 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.00 | $35.82 | 0.50% | 14.23x | 9.78x | 2.32x | 2.29x | 0.54x | $341.79M | 16.42% | $910.35M | 15.75 | $1.65B | 6.98 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.22 | $5.75 | -61.37% | 8.22x | 3.25x | 2.08x | 2.43x | 0.17x | $7.24M | 5.68% | $52.93M | 0.92 | $74.89M | 4.83 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $498.01 | $168.27 | 195.95% | 29.28x | 25.48x | 10.36x | 6.53x | 2.14x | $3.71B | 2.93% | $19.36B | 76.20 | $122.89B | 22.79 | ||
| UTHR | UNITED THERAPEUTICS CORP | $547.15 | $243.74 | 124.48% | 18.69x | 19.23x | 7.51x | 3.94x | 2.07x | $1.02B | 4.27% | $5.90B | 135.66 | $21.95B | 12.81 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.33 | $2.46 | 35.11% | 13.88x | 14.07x | 2.04x | 3.22x | 0.94x | $4.11M | 1.53% | $82.33M | 1.03 | $201.24M | 9.47 | ||
| EXEL | EXELIXIS INC | $53.96 | $30.91 | 74.58% | 17.29x | 16.38x | 5.87x | 7.01x | 1.26x | $917.69M | 6.58% | $1.94B | 7.49 | $13.51B | 12.79 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.44 | $12.27 | 156.19% | 17.37x | 16.03x | 6.44x | 3.80x | 3.90x | $208.13M | 5.41% | $1.01B | 8.28 | $3.09B | 9.24 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $624.72 | $436.88 | 43.00% | 14.68x | 13.28x | 4.35x | 2.08x | 0.99x | $4.11B | 6.33% | $31.42B | 302.15 | $65.24B | 11.36 | ||
| INCY | INCYTE CORP | $113.81 | $67.00 | 69.87% | 15.61x | 14.53x | 4.23x | 4.04x | 1.34x | $1.45B | 6.39% | $5.62B | 28.21 | $19.31B | 10.32 | ||
| VCYT | VERACYTE INC | $59.85 | $7.62 | 685.87% | 53.92x | 53.67x | 8.79x | 3.55x | 11.48x | $155.34M | 3.26% | $1.34B | 16.90 | $4.55B | 39.55 | ||
| MDXG | MIMEDX GROUP INC | $3.90 | $1.26 | 210.14% | 18.57x | -46.32x | 1.49x | 2.39x | 8.83x | $69.36M | 11.97% | $242.94M | 1.64 | $438.71M | 8.05 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $18.20 | $3.61 | 403.53% | 30.33x | 4.97x | 0.87x | 1.28x | 13.73x | $109.24M | 5.71% | $1.51B | 14.34 | $2.49B | 30.14 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.